{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:37:58Z","timestamp":1786113478840,"version":"build-2736575974"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100017170","name":"Thailand Science Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017170","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004156","name":"Mahidol University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017413","name":"Innovation Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017413","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012309","name":"Royal Golden Jubilee (RGJ) Ph.D. Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012309","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.cbi.2026.112217","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T15:38:00Z","timestamp":1782229080000},"page":"112217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Identification of antiproliferative nogalamycin series as potent inhibitors of EGFR tyrosine kinase: An in vitro and computational study"],"prefix":"10.1016","volume":"436","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4501-5113","authenticated-orcid":false,"given":"Chatchakorn","family":"Eurtivong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5918-8704","authenticated-orcid":false,"given":"Thomanai","family":"Lamtha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nattanan","family":"Jiwacharoenchai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng Chieh","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8279-1779","authenticated-orcid":false,"given":"Rungroj","family":"Saruengkhanphasit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Worawat","family":"Niwetmarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnatchai","family":"Maiuthed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lueacha","family":"Tabtimmai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supaphorn","family":"Seetaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somsak","family":"Ruchirawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiattawee","family":"Choowongkomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2026.112217_bib1","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.cbi.2026.112217_bib2","first-page":"67","article-title":"Known and putative mechanisms of resistance to EGFR targeted therapies in NSCLC patients with EGFR mutations-a review","volume":"4","author":"Stewart","year":"2015","journal-title":"Transl. Lung Cancer Res."},{"key":"10.1016\/j.cbi.2026.112217_bib3","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/568938","article-title":"Targeting the epidermal growth factor receptor in epithelial ovarian cancer: current knowledge and future challenges","volume":"2010","author":"Siwak","year":"2010","journal-title":"J. Oncol."},{"key":"10.1016\/j.cbi.2026.112217_bib4","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.2174\/1389557516666160321114917","article-title":"Review on EGFR inhibitors: critical updates","volume":"16","author":"Singh","year":"2016","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.cbi.2026.112217_bib5","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/modpathol.2008.182","article-title":"Evaluation of EGFR abnormalities in patients with pulmonary adenocarcinoma: the need to test neoplasms with more than one method","volume":"22","author":"Gupta","year":"2009","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.cbi.2026.112217_bib6","article-title":"EGFR-mutated squamous cell lung cancer and its association with outcomes","volume":"11","author":"Jin","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cbi.2026.112217_bib7","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nature17960","article-title":"Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors","volume":"534","author":"Jia","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.cbi.2026.112217_bib8","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1158\/2159-8290.CD-18-0903","article-title":"Single and dual targeting of mutant EGFR with an allosteric inhibitor","volume":"9","author":"To","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.cbi.2026.112217_bib9","first-page":"836","article-title":"Fermentation, taxonomic, and biological studies on nogalamycin","volume":"5","author":"Bhuyan","year":"1965","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.cbi.2026.112217_bib10","first-page":"984","article-title":"Comparative biological activity of nogalamycin and its analogs","volume":"30","author":"Bhuyan","year":"1970","journal-title":"Cancer Res."},{"key":"10.1016\/j.cbi.2026.112217_bib11","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1021\/bi00219a029","article-title":"DNA-nogalamycin interactions","volume":"30","author":"Egli","year":"1991","journal-title":"Biochemistry"},{"key":"10.1016\/j.cbi.2026.112217_bib12","doi-asserted-by":"crossref","first-page":"13285","DOI":"10.1021\/bi971261x","article-title":"Differential poisoning of topoisomerases by menogaril and nogalamycin dictated by the minor groove-binding nogalose sugar","volume":"36","author":"Sim","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.cbi.2026.112217_bib13","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1021\/jm00347a016","article-title":"Structure--activity relationships of nogalamycin analogues","volume":"25","author":"Wiley","year":"1982","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2026.112217_bib14","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1002\/jcb.27605","article-title":"In silico identification and in vitro validation of nogalamycin N-oxide (NSC116555) as a potent anticancer compound against non-small-cell lung cancer cells","volume":"120","author":"Obounchoey","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.cbi.2026.112217_bib15","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1124\/pr.112.007336","article-title":"Computational methods in drug discovery","volume":"66","author":"Sliwoski","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.cbi.2026.112217_bib16","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1016\/j.bmc.2016.05.061","article-title":"Identification of anticancer agents based on the thieno[2,3-b]pyridine and 1H-pyrazole molecular scaffolds","volume":"24","author":"Eurtivong","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.cbi.2026.112217_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.128524","article-title":"Discovery of potent antiproliferative agents from selected oxygen heterocycles as EGFR tyrosine kinase inhibitors from the U.S. National Cancer Institute database by in silico screening and bioactivity evaluation","volume":"58","author":"Jiwacharoenchai","year":"2022","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.cbi.2026.112217_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmgm.2020.107639","article-title":"Molecular dynamics, MM\/PBSA and in vitro validation of a novel quinazoline-based EGFR tyrosine kinase inhibitor identified using structure-based in silico screening","volume":"99","author":"Ornnork","year":"2020","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.cbi.2026.112217_bib19","doi-asserted-by":"crossref","first-page":"9960","DOI":"10.1021\/acs.analchem.5b02572","article-title":"Quantification of epidermal growth factor receptor expression level and binding kinetics on cell surfaces by surface plasmon resonance imaging","volume":"87","author":"Zhang","year":"2015","journal-title":"Anal. Chem."},{"key":"10.1016\/j.cbi.2026.112217_bib20","first-page":"2594","article-title":"Multidrug resistance in a human small cell lung cancer cell line selected in adriamycin","volume":"47","author":"Mirski","year":"1987","journal-title":"Cancer Res."},{"key":"10.1016\/j.cbi.2026.112217_bib21","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1479-5876-7-47","article-title":"PAR1 is selectively over expressed in high grade breast cancer patients: a cohort study","volume":"7","author":"Hern\u00e1ndez","year":"2009","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.cbi.2026.112217_bib22","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1006\/jmbi.1999.2903","article-title":"Structure, dynamics and hydration of the nogalamycin-d(ATGCAT)2Complex determined by NMR and molecular dynamics simulations in solution","volume":"290","author":"Williams","year":"1999","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.cbi.2026.112217_bib23","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1006\/jmbi.1993.1208","article-title":"Interactions between morpholinyl anthracyclines and DNA. The crystal structure of a morpholino doxorubicin bound to d(CGTACG)","volume":"230","author":"Cirilli","year":"1993","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.cbi.2026.112217_bib24","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1161\/ATVBAHA.117.310068","article-title":"Protease-activated Receptor-1 signaling: the big picture","volume":"37","author":"Flaumenhaft","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cbi.2026.112217_bib25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s43556-021-00036-1","article-title":"G-protein coupled receptor, PI3K and Rho signaling pathways regulate the cascades of Tau and amyloid-\u03b2 in Alzheimer's disease","volume":"2","author":"Desale","year":"2021","journal-title":"Mol. Biomed."},{"key":"10.1016\/j.cbi.2026.112217_bib26","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.3390\/pharmaceutics15082130","article-title":"Targeting EGFR\/PI3K\/AKT\/mTOR signaling in hepatocellular carcinoma","volume":"15","author":"Bang","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.cbi.2026.112217_bib27","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1038\/s41467-020-16952-9","article-title":"Multiple low dose therapy as an effective strategy to treat EGFR inhibitor-resistant NSCLC tumours","volume":"11","author":"Fernandes Neto","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cbi.2026.112217_bib28","doi-asserted-by":"crossref","first-page":"10890","DOI":"10.1002\/anie.201603736","article-title":"Lung cancer: EGFR inhibitors with low nanomolar activity against a therapy-resistant L858R\/T790M\/C797S mutant","volume":"55","author":"G\u00fcnther","year":"2016","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.cbi.2026.112217_bib29","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/prot.10465","article-title":"Improved protein-ligand docking using GOLD","volume":"52","author":"Verdonk","year":"2003","journal-title":"Proteins"},{"key":"10.1016\/j.cbi.2026.112217_bib30","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1023\/A:1007996124545","article-title":"Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes","volume":"11","author":"Eldridge","year":"1997","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.cbi.2026.112217_bib31","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1021\/ci800298z","article-title":"Empirical scoring functions for advanced protein-ligand docking with PLANTS","volume":"49","author":"Korb","year":"2009","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.cbi.2026.112217_bib32","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/prot.20588","article-title":"General and targeted statistical potentials for protein-ligand interactions","volume":"61","author":"Mooij","year":"2005","journal-title":"Proteins"},{"key":"10.1016\/j.cbi.2026.112217_bib33","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1128\/MCB.00248-15","article-title":"Analysis of the role of the C-Terminal tail in the regulation of the epidermal growth factor receptor","volume":"35","author":"Kovacs","year":"2015","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.cbi.2026.112217_bib34","doi-asserted-by":"crossref","first-page":"46265","DOI":"10.1074\/jbc.M207135200","article-title":"Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor","volume":"277","author":"Stamos","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2026.112217_bib35","doi-asserted-by":"crossref","first-page":"26325","DOI":"10.1039\/D4RA04828H","article-title":"S-Alkylated quinazolin-4(3H)-ones as dual EGFR\/VEGFR-2 kinases inhibitors: design, synthesis, anticancer evaluation and docking study","volume":"14","author":"Tawfik","year":"2024","journal-title":"RSC Adv."},{"key":"10.1016\/j.cbi.2026.112217_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107951","article-title":"Harnessing potential COX-2 engagement for boosting anticancer activity of substituted 2-mercapto-4(3H)-quinazolinones with promising EGFR\/VEGFR-2 inhibitory activities","volume":"153","author":"Hamdi","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.cbi.2026.112217_bib37","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ejmech.2015.12.032","article-title":"Design and discovery of 4-anilinoquinazoline-acylamino derivatives as EGFR and VEGFR-2 dual TK inhibitors","volume":"109","author":"Zhang","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cbi.2026.112217_bib38","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.3390\/ph18071051","article-title":"Purine\u2013hydrazone scaffolds as potential dual EGFR\/HER2 inhibitors","volume":"18","author":"Albalawi","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.cbi.2026.112217_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsps.2023.101803","article-title":"Synthesis of novel spirochromane incorporating Schiff's bases, potential antiproliferative activity, and dual EGFR\/HER2 inhibition: cell cycle analysis and in silico study","volume":"31","author":"Othman","year":"2023","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.cbi.2026.112217_bib40","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1042\/BJ20121513","article-title":"Erlotinib binds both inactive and active conformations of the EGFR tyrosine kinase domain","volume":"448","author":"Park","year":"2012","journal-title":"Biochem. J."},{"key":"10.1016\/j.cbi.2026.112217_bib41","doi-asserted-by":"crossref","first-page":"6652","DOI":"10.1158\/0008-5472.CAN-04-1168","article-title":"A unique structure for epidermal growth factor receptor bound to GW572016 (Lapatinib): relationships among protein conformation, inhibitor off-rate, and receptor activity in tumor cells","volume":"64","author":"Wood","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.cbi.2026.112217_bib42","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13321-019-0362-7","article-title":"DockRMSD: an open-source tool for atom mapping and RMSD calculation of symmetric molecules through graph isomorphism","volume":"11","author":"Bell","year":"2019","journal-title":"J. Cheminf."},{"key":"10.1016\/j.cbi.2026.112217_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23051038","article-title":"Is it reliable to take the molecular docking top scoring position as the best solution without considering available structural data?","volume":"23","author":"Ram\u00edrez","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.cbi.2026.112217_bib44","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jmgm.2015.03.002","article-title":"Molecular dynamics of the asymmetric dimers of EGFR: simulations on the active and inactive conformations of the kinase domain","volume":"58","author":"Songtawee","year":"2015","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.cbi.2026.112217_bib45","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00894-012-1559-0","article-title":"Computational study of EGFR inhibition: molecular dynamics studies on the active and inactive protein conformations","volume":"19","author":"Songtawee","year":"2013","journal-title":"J. Mol. Model."},{"key":"10.1016\/j.cbi.2026.112217_bib46","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1080\/10799893.2019.1590411","article-title":"Molecular docking and dynamics studies of 4-anilino quinazolines for epidermal growth factor receptor tyrosine kinase to find potent inhibitor","volume":"38","author":"Muthuvel","year":"2018","journal-title":"J. Recept. Signal Transduction"},{"key":"10.1016\/j.cbi.2026.112217_bib47","doi-asserted-by":"crossref","first-page":"895","DOI":"10.3390\/molecules25040895","article-title":"How different substitution positions of F, Cl atoms in benzene ring of 5-Methylpyrimidine pyridine derivatives affect the inhibition ability of EGFRL858R\/T790M\/C797S inhibitors: a molecular dynamics simulation study","volume":"25","author":"E","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.cbi.2026.112217_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmgm.2021.108114","article-title":"Studies on ligand-based pharmacophore modeling approach in identifying potent future EGFR inhibitors","volume":"112","author":"Shaikh","year":"2022","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.cbi.2026.112217_bib49","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cbi.2026.112217_bib50","doi-asserted-by":"crossref","first-page":"W296","DOI":"10.1093\/nar\/gky427","article-title":"SWISS-MODEL: homology modelling of protein structures and complexes","volume":"46","author":"Waterhouse","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cbi.2026.112217_bib51","doi-asserted-by":"crossref","DOI":"10.1002\/minf.201800068","article-title":"The development of a weighted index to optimise compound libraries for high throughput screening","volume":"38","author":"Eurtivong","year":"2019","journal-title":"Mol. Inf."},{"key":"10.1016\/j.cbi.2026.112217_bib52","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.cbi.2026.112217_bib53","doi-asserted-by":"crossref","first-page":"8127","DOI":"10.1021\/ja00467a001","article-title":"Conformational analysis. 130. MM2. A hydrocarbon force field utilizing V1 and V2 torsional terms","volume":"99","author":"Allinger","year":"1977","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.cbi.2026.112217_bib54","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0076-6879(97)77022-8","article-title":"VERIFY3D: assessment of protein models with three-dimensional profiles","volume":"277","author":"Eisenberg","year":"1997","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.cbi.2026.112217_bib55","doi-asserted-by":"crossref","first-page":"W407","DOI":"10.1093\/nar\/gkm290","article-title":"ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins","volume":"35","author":"Wiederstein","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cbi.2026.112217_bib56","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/protein\/8.2.127","article-title":"LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions","volume":"8","author":"Wallace","year":"1995","journal-title":"Protein Eng."},{"key":"10.1016\/j.cbi.2026.112217_bib57","series-title":"GROMACS User Manual Version 5.1.4","author":"Abraham","year":"2016"},{"key":"10.1016\/j.cbi.2026.112217_bib58","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0010-4655(95)00042-E","article-title":"GROMACS: a message-passing parallel molecular dynamics implementation","volume":"91","author":"Berendsen","year":"1995","journal-title":"Comput. Phys. Commun."},{"key":"10.1016\/j.cbi.2026.112217_bib59","doi-asserted-by":"crossref","first-page":"4026","DOI":"10.1021\/ct200196m","article-title":"An automated force field topology builder (ATB) and repository: version 1.0","volume":"7","author":"Malde","year":"2011","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.cbi.2026.112217_bib60","doi-asserted-by":"crossref","first-page":"5834","DOI":"10.1021\/acs.jctc.8b00768","article-title":"Automated topology builder version 3.0: prediction of solvation free enthalpies in water and hexane","volume":"14","author":"Stroet","year":"2018","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.cbi.2026.112217_bib61","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s00249-011-0700-9","article-title":"Definition and testing of the GROMOS force-field versions 54A7 and 54B7","volume":"40","author":"Schmid","year":"2011","journal-title":"Eur. Biophys. J."},{"key":"10.1016\/j.cbi.2026.112217_bib62","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0009-2614(94)01391-8","article-title":"Force field parametrization by weak coupling. Re-engineering SPC water","volume":"232","author":"Berweger","year":"1995","journal-title":"Chem. Phys. Lett."},{"key":"10.1016\/j.cbi.2026.112217_bib63","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1063\/1.448118","article-title":"Molecular dynamics with coupling to an external bath","volume":"81","author":"Berendsen","year":"1984","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.cbi.2026.112217_bib64","doi-asserted-by":"crossref","first-page":"7182","DOI":"10.1063\/1.328693","article-title":"Polymorphic transitions in single crystals: a new molecular dynamics method","volume":"52","author":"Parrinello","year":"1981","journal-title":"J. Appl. Phys."},{"key":"10.1016\/j.cbi.2026.112217_bib65","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","article-title":"A linear constraint solver for molecular simulations","volume":"18","author":"Hess","year":"1997","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.cbi.2026.112217_bib66","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1063\/1.464397","article-title":"Particle mesh Ewald: an N\u22c5log(N) method for Ewald sums in large systems","volume":"98","author":"Darden","year":"1993","journal-title":"J. Chem. Phys."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000927972600325X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000927972600325X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T19:32:34Z","timestamp":1785958354000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000927972600325X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":66,"alternative-id":["S000927972600325X"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2026.112217","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of antiproliferative nogalamycin series as potent inhibitors of EGFR tyrosine kinase: An in vitro and computational study","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2026.112217","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"112217"}}